Industry: Medical Devices & Consumables
Published Date: 2025-01-01
Pages: 91 Pages
Report ld: 3442656
Request Sample
Customized Report
The global market for Human NK Cell Isolation Kit was valued at US$ 282 million in the year 2023 and is projected to reach a revised size of US$ 444 million by 2030, growing at a CAGR of 6.5% during the forecast period.
The Human NK Cell Isolation Kit is designed to magnetically isolate NK cells from a complex immune cell population. The kit is optimized for the isolation of CD56+CD3- cells from normal human peripheral blood mononuclear cells (PBMCs). The cells are incubated with a cocktail of antibodies and then bound to magnetic beads. They are then placed on a magnet for quick and easy separation. When placed on the magnet, non-NK cells will be fixed to the side of the tube, while NK cells will remain in suspension and can be easily removed for downstream applications.
North American market for Human NK Cell Isolation Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human NK Cell Isolation Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human NK Cell Isolation Kit include BPS Bioscience, Miltenyi Biotec, Novus Biologicals, STEMCELL Technologies, Thermo Fisher Scientific, RWD, Xinxie Biotechnology, Jinzhun Biotechnology, R&D Systems, BioLegend, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human NK Cell Isolation Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human NK Cell Isolation Kit.
The Human NK Cell Isolation Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human NK Cell Isolation Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human NK Cell Isolation Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human NK Cell Isolation Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human NK Cell Isolation Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Human NK Cell Isolation Kit Market Overview
1.1 Product Definition
1.2 Human NK Cell Isolation Kit by Type
1.2.1 Global Human NK Cell Isolation Kit Market Value Comparison by Type (2024-2030)
1.2.2 1 x 10^8 Cells
1.2.3 1 x 10^9 Cells
1.2.4 Other
1.3 Human NK Cell Isolation Kit by Application
1.3.1 Global Human NK Cell Isolation Kit Market Value by Application (2024-2030)
1.3.2 Research Institute
1.3.3 School
1.3.4 Other
1.4 Global Human NK Cell Isolation Kit Market Size Estimates and Forecasts
1.4.1 Global Human NK Cell Isolation Kit Revenue 2019-2030
1.4.2 Global Human NK Cell Isolation Kit Sales 2019-2030
1.4.3 Global Human NK Cell Isolation Kit Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human NK Cell Isolation Kit Market Competition by Manufacturers
2.1 Global Human NK Cell Isolation Kit Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human NK Cell Isolation Kit Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human NK Cell Isolation Kit Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Human NK Cell Isolation Kit, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human NK Cell Isolation Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human NK Cell Isolation Kit, Product Type & Application
2.7 Global Key Manufacturers of Human NK Cell Isolation Kit, Date of Enter into This Industry
2.8 Global Human NK Cell Isolation Kit Market Competitive Situation and Trends
2.8.1 Global Human NK Cell Isolation Kit Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human NK Cell Isolation Kit Players Market Share by Revenue
2.8.3 Global Human NK Cell Isolation Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human NK Cell Isolation Kit Market Scenario by Region
3.1 Global Human NK Cell Isolation Kit Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human NK Cell Isolation Kit Sales by Region: 2019-2030
3.2.1 Global Human NK Cell Isolation Kit Sales by Region: 2019-2024
3.2.2 Global Human NK Cell Isolation Kit Sales by Region: 2025-2030
3.3 Global Human NK Cell Isolation Kit Revenue by Region: 2019-2030
3.3.1 Global Human NK Cell Isolation Kit Revenue by Region: 2019-2024
3.3.2 Global Human NK Cell Isolation Kit Revenue by Region: 2025-2030
3.4 North America Human NK Cell Isolation Kit Market Facts & Figures by Country
3.4.1 North America Human NK Cell Isolation Kit Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human NK Cell Isolation Kit Sales by Country (2019-2030)
3.4.3 North America Human NK Cell Isolation Kit Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human NK Cell Isolation Kit Market Facts & Figures by Country
3.5.1 Europe Human NK Cell Isolation Kit Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human NK Cell Isolation Kit Sales by Country (2019-2030)
3.5.3 Europe Human NK Cell Isolation Kit Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human NK Cell Isolation Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Human NK Cell Isolation Kit Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human NK Cell Isolation Kit Sales by Region (2019-2030)
3.6.3 Asia Pacific Human NK Cell Isolation Kit Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human NK Cell Isolation Kit Market Facts & Figures by Country
3.7.1 Latin America Human NK Cell Isolation Kit Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human NK Cell Isolation Kit Sales by Country (2019-2030)
3.7.3 Latin America Human NK Cell Isolation Kit Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human NK Cell Isolation Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Human NK Cell Isolation Kit Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human NK Cell Isolation Kit Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human NK Cell Isolation Kit Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human NK Cell Isolation Kit Sales by Type (2019-2030)
4.1.1 Global Human NK Cell Isolation Kit Sales by Type (2019-2024)
4.1.2 Global Human NK Cell Isolation Kit Sales by Type (2025-2030)
4.1.3 Global Human NK Cell Isolation Kit Sales Market Share by Type (2019-2030)
4.2 Global Human NK Cell Isolation Kit Revenue by Type (2019-2030)
4.2.1 Global Human NK Cell Isolation Kit Revenue by Type (2019-2024)
4.2.2 Global Human NK Cell Isolation Kit Revenue by Type (2025-2030)
4.2.3 Global Human NK Cell Isolation Kit Revenue Market Share by Type (2019-2030)
4.3 Global Human NK Cell Isolation Kit Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human NK Cell Isolation Kit Sales by Application (2019-2030)
5.1.1 Global Human NK Cell Isolation Kit Sales by Application (2019-2024)
5.1.2 Global Human NK Cell Isolation Kit Sales by Application (2025-2030)
5.1.3 Global Human NK Cell Isolation Kit Sales Market Share by Application (2019-2030)
5.2 Global Human NK Cell Isolation Kit Revenue by Application (2019-2030)
5.2.1 Global Human NK Cell Isolation Kit Revenue by Application (2019-2024)
5.2.2 Global Human NK Cell Isolation Kit Revenue by Application (2025-2030)
5.2.3 Global Human NK Cell Isolation Kit Revenue Market Share by Application (2019-2030)
5.3 Global Human NK Cell Isolation Kit Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BPS Bioscience
6.1.1 BPS Bioscience Company Information
6.1.2 BPS Bioscience Description and Business Overview
6.1.3 BPS Bioscience Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BPS Bioscience Human NK Cell Isolation Kit Product Portfolio
6.1.5 BPS Bioscience Recent Developments/Updates
6.2 Miltenyi Biotec
6.2.1 Miltenyi Biotec Company Information
6.2.2 Miltenyi Biotec Description and Business Overview
6.2.3 Miltenyi Biotec Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Miltenyi Biotec Human NK Cell Isolation Kit Product Portfolio
6.2.5 Miltenyi Biotec Recent Developments/Updates
6.3 Novus Biologicals
6.3.1 Novus Biologicals Company Information
6.3.2 Novus Biologicals Description and Business Overview
6.3.3 Novus Biologicals Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novus Biologicals Human NK Cell Isolation Kit Product Portfolio
6.3.5 Novus Biologicals Recent Developments/Updates
6.4 STEMCELL Technologies
6.4.1 STEMCELL Technologies Company Information
6.4.2 STEMCELL Technologies Description and Business Overview
6.4.3 STEMCELL Technologies Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 STEMCELL Technologies Human NK Cell Isolation Kit Product Portfolio
6.4.5 STEMCELL Technologies Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Thermo Fisher Scientific Human NK Cell Isolation Kit Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 RWD
6.6.1 RWD Company Information
6.6.2 RWD Description and Business Overview
6.6.3 RWD Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.6.4 RWD Human NK Cell Isolation Kit Product Portfolio
6.6.5 RWD Recent Developments/Updates
6.7 Xinxie Biotechnology
6.7.1 Xinxie Biotechnology Company Information
6.7.2 Xinxie Biotechnology Description and Business Overview
6.7.3 Xinxie Biotechnology Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Xinxie Biotechnology Human NK Cell Isolation Kit Product Portfolio
6.7.5 Xinxie Biotechnology Recent Developments/Updates
6.8 Jinzhun Biotechnology
6.8.1 Jinzhun Biotechnology Company Information
6.8.2 Jinzhun Biotechnology Description and Business Overview
6.8.3 Jinzhun Biotechnology Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jinzhun Biotechnology Human NK Cell Isolation Kit Product Portfolio
6.8.5 Jinzhun Biotechnology Recent Developments/Updates
6.9 R&D Systems
6.9.1 R&D Systems Company Information
6.9.2 R&D Systems Description and Business Overview
6.9.3 R&D Systems Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.9.4 R&D Systems Human NK Cell Isolation Kit Product Portfolio
6.9.5 R&D Systems Recent Developments/Updates
6.10 BioLegend
6.10.1 BioLegend Company Information
6.10.2 BioLegend Description and Business Overview
6.10.3 BioLegend Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.10.4 BioLegend Human NK Cell Isolation Kit Product Portfolio
6.10.5 BioLegend Recent Developments/Updates
6.11 Proteintech Group
6.11.1 Proteintech Group Company Information
6.11.2 Proteintech Group Description and Business Overview
6.11.3 Proteintech Group Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Proteintech Group Human NK Cell Isolation Kit Product Portfolio
6.11.5 Proteintech Group Recent Developments/Updates
6.12 Stemery
6.12.1 Stemery Company Information
6.12.2 Stemery Description and Business Overview
6.12.3 Stemery Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Stemery Human NK Cell Isolation Kit Product Portfolio
6.12.5 Stemery Recent Developments/Updates
6.13 Creative Bioarray
6.13.1 Creative Bioarray Company Information
6.13.2 Creative Bioarray Description and Business Overview
6.13.3 Creative Bioarray Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Creative Bioarray Human NK Cell Isolation Kit Product Portfolio
6.13.5 Creative Bioarray Recent Developments/Updates
6.14 LubioScience
6.14.1 LubioScience Company Information
6.14.2 LubioScience Description and Business Overview
6.14.3 LubioScience Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.14.4 LubioScience Human NK Cell Isolation Kit Product Portfolio
6.14.5 LubioScience Recent Developments/Updates
6.15 Immocell
6.15.1 Immocell Company Information
6.15.2 Immocell Description and Business Overview
6.15.3 Immocell Human NK Cell Isolation Kit Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Immocell Human NK Cell Isolation Kit Product Portfolio
6.15.5 Immocell Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human NK Cell Isolation Kit Industry Chain Analysis
7.2 Human NK Cell Isolation Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human NK Cell Isolation Kit Production Mode & Process
7.4 Human NK Cell Isolation Kit Sales and Marketing
7.4.1 Human NK Cell Isolation Kit Sales Channels
7.4.2 Human NK Cell Isolation Kit Distributors
7.5 Human NK Cell Isolation Kit Customers
8 Human NK Cell Isolation Kit Market Dynamics
8.1 Human NK Cell Isolation Kit Industry Trends
8.2 Human NK Cell Isolation Kit Market Drivers
8.3 Human NK Cell Isolation Kit Market Challenges
8.4 Human NK Cell Isolation Kit Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Human NK Cell Isolation Kit market is projected to grow from US$ 322 million in 2025 to US$ 497 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 159
USD 4900.00
(Single User License)
The global Human NK Cell Isolation Kit market size was US$ 322 million in 2025 and is forecast to reach a readjusted size of US$ 497 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 91
USD 4250.00
(Single User License)
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 322 million in 2025 and is projected to reach US$ 497 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 115
USD 3950.00
(Single User License)
The global Human NK Cell Isolation Kit market was valued at US$ 322 million in 2025 and is anticipated to reach US$ 497 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 121
USD 2900.00
(Single User License)
The global Human NK Cell Isolation Kit market size was US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 4250.00
(Single User License)
The global Human NK Cell Isolation Kit market is projected to grow from US$ 304 million in 2024 to US$ 470 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 153
USD 4900.00
(Single User License)
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 123
USD 3950.00
(Single User License)
The global market for Human NK Cell Isolation Kit was valued at US$ 304 million in the year 2024 and is projected to reach a revised size of US$ 470 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-03-10
Pages: 97
USD 2900.00
(Single User License)
The global Human NK Cell Isolation Kit revenue was US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 140
USD 4350.00
(Single User License)
Valued at US$ 304 million in 2024, the global Human NK Cell Isolation Kit market is forecast to reach US$ 444 million by 2030, at a CAGR of 6.5% during the forecast period.
Published Date: 2025-01-01
Pages: 161
USD 4900.00
(Single User License)
The global Human NK Cell Isolation Kit market is projected to grow from US$ 322 million in 2025 to US$ 497 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 159
The global Human NK Cell Isolation Kit market size was US$ 322 million in 2025 and is forecast to reach a readjusted size of US$ 497 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 91
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 322 million in 2025 and is projected to reach US$ 497 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-19
Pages: 115
The global Human NK Cell Isolation Kit market was valued at US$ 322 million in 2025 and is anticipated to reach US$ 497 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 121
The global Human NK Cell Isolation Kit market size was US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
The global Human NK Cell Isolation Kit market is projected to grow from US$ 304 million in 2024 to US$ 470 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 153
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 123
The global market for Human NK Cell Isolation Kit was valued at US$ 304 million in the year 2024 and is projected to reach a revised size of US$ 470 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-03-10
Pages: 97
The global Human NK Cell Isolation Kit revenue was US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published: 2025-01-01
Pages: 140
Valued at US$ 304 million in 2024, the global Human NK Cell Isolation Kit market is forecast to reach US$ 444 million by 2030, at a CAGR of 6.5% during the forecast period.
Published: 2025-01-01
Pages: 161
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now